Oregon is currently home to 1217 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Portland, Eugene, Medford and Clackamas. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.
NCT05042674
Recruiting
A trial on acute antioxidant protection and immune effects when 24 people consume a novel nutraceutical blend compared to a placebo on different test days.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
06/07/2022
Locations: NIS Labs, Klamath Falls, Oregon
Conditions: Pharmacokinetics
Register for Updates
Clinical Proof-of-concept Study on Rapid Immune Modulating Effects
NCT05364710
Recruiting
Clinical-proof-of concept study, comparing the acute immune impacts of of 2 doses of a novel blend of supplements to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 2 different doses of the blend at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the blend on immune function as compared to the placebo.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
05/11/2022
Locations: NIS Labs, Klamath Falls, Oregon
Conditions: Immune Surveillance
Register for Updates
Exercise in Pregnant Women With Gestational Diabetes
NCT04145479
Recruiting
Gestational diabetes (GDM) impacts 1 in 10 pregnancies; hyperglycemia and hypertriglyceridemia are common features of the condition. Women are recommended to do at least 150 minutes of moderate-intensity aerobic activity a week during pregnancy and the postpartum period. Exercise both during and out of pregnancy has been shown to be an effective non-pharmacologic tool to reduce glucose and lipid profiles. The goals and purpose of this pilot study is to 1) determine the influence of exercise and... Read More
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
04/27/2022
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Gestational Diabetes
Register for Updates
BFR Training on a Bike to Augment RC Strength, Leg Strength, and VO2 Peak
NCT05344391
Recruiting
This study will investigate if subjects who bike at 40% of heart rate reserve (HRR) with blood flow restriction (BFR) applied to bilateral thighs for 10 minutes (at 80% limb occlusion pressure) will experience greater gains in 10 rep max for dominant lower extremity leg press, greater gains in rotator cuff strength (hand held dynamometer testing for supraspinatus and external rotators) and greater gains in VO2 peak.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/22/2022
Locations: College of Physical Therapy / George Fox University, Newberg, Oregon
Conditions: Can BFR Cycling Augment Strength and VO2peak
Register for Updates
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
NCT03753243
Recruiting
Pembrolizumab will be administered at a dose of 200 mg will be administered as a 30 minute IV infusion every 3 weeks. Enzalutamide will be administered at dose of 160 mg orally every day. All patients will be required to have at least one high-risk criteria.
Gender:
Male
Ages:
18 years and above
Trial Updated:
04/19/2022
Locations: VA Portland Healthcare System, Portland, Oregon
Conditions: Prostate Cancer
Register for Updates
Two Time a Week vs. Five Time a Week Blood Flow Restriction Training Program for the Lower Extremity.
NCT05342909
Recruiting
This study will randomize healthy adults who regularly perform resistance training exercises for the lower extremities (2x a week) to one of three groups: a blood flow restriction (BFR) exercise group that trains 2x a week, a BFR exercise group that trains 5x a week, and a control group that does not perform any additional BFR exercise. Those randomized to the BFR groups will perform the unilateral 90-0 knee extension exercise followed by the bilateral squat. Subjects will have the BFR applied t... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2022
Locations: George Fox University School of Physical Therapy, Newberg, Oregon
Conditions: Blood Flow Restriction Training
Register for Updates
Clinical and Genetic Analysis of ROP
NCT04420156
Recruiting
Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel that this study will result in specific knowledge discovery about ROP, as well as general knowledge about how image-based data and genetic data can be combined to better understand clinical... Read More
Gender:
All
Ages:
1 year and below
Trial Updated:
04/18/2022
Locations: Oregon Health & Science University, Portland, Oregon
Conditions: Retinopathy of Prematurity
Register for Updates
Supracondylar Pinning Antibiotic Stewardship (SPAS) Trial
NCT04288206
Recruiting
Prospective, multi-center, randomized controlled trial studying infection rate with or without prophylactic antibiotics at the time of closed reduction and percutaneous pinning of pediatric supracondylar humerus fractures.
Gender:
All
Ages:
Between 0 years and 18 years
Trial Updated:
04/08/2022
Locations: Legacy Emanuel Medical Center, Portland, Oregon
Conditions: Supracondylar Humerus Fracture, Infection
Register for Updates
Pilot Study of BCAA on Sleep
NCT03990909
Recruiting
Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health & Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimenta... Read More
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
04/04/2022
Locations: VA Portland Health Care System, Portland, Oregon
Conditions: Sleep Disorder, Traumatic Brain Injury
Register for Updates
Improving Sleep, Sleep-related Outcomes, and Biomarkers in Veterans
NCT03968874
Recruiting
The primary purpose of this project is to determine the effect of morning bright light therapy (MBLT) on sleep in Veterans with traumatic brain injury (TBI). Secondarily, the project aims to identify blood-based brain biomarkers (BBBM) associated with sleep in Veterans. Specific Aim 1. Determine the effect of MBLT on sleep quality in Veterans (primary outcome). Specific Aim 2. Determine the effect of MBLT on downstream effectors of improved sleep, including cognition, mood, and quality of life... Read More
Gender:
All
Ages:
Between 18 years and 88 years
Trial Updated:
04/04/2022
Locations: Portland VA Medical Center, Portland, Oregon
Conditions: Traumatic Brain Injury
Register for Updates
Morning Bright Light to Improve Sleep Quality in Veterans
NCT03578003
Recruiting
One of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a variety of conditions, but little has been done investigating the utility of MBLT in improving sleep in Veterans with TBI. This proposal aims to determine the effect of MBLT on sleep quality in Veterans with TBI. Vetera... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/04/2022
Locations: VA Portland Health Care System, Portland, Oregon
Conditions: Brain Injuries, Traumatic, Post-traumatic Stress Disorder
Register for Updates
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
NCT04775537
Recruiting
The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
Gender:
All
Ages:
18 years and above
Trial Updated:
03/08/2022
Locations: McKenzie-willamette Medical Center, Eugene, Oregon
Conditions: Spinal Disease, Degenerative Disc Disease
Register for Updates